Xtant Medical Holdings, Inc. (XTNT)
 NYSEAMERICAN: XTNT · Real-Time Price · USD
 0.8540
 +0.0425 (5.24%)
  Nov 4, 2025, 9:34 AM EST - Market open
Xtant Medical Holdings Revenue
Xtant Medical Holdings had revenue of $35.41M in the quarter ending June 30, 2025, with 18.26% growth. This brings the company's revenue in the last twelve months to $127.77M, up 15.16% year-over-year. In the year 2024, Xtant Medical Holdings had annual revenue of $117.27M with 28.44% growth.
Revenue (ttm) 
 $127.77M
Revenue Growth 
 +15.16%
P/S Ratio 
 0.88
Revenue / Employee 
 $550,716
Employees 
 232
Market Cap 
119.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 117.27M | 25.96M | 28.44% | 
| Dec 31, 2023 | 91.30M | 33.33M | 57.50% | 
| Dec 31, 2022 | 57.97M | 2.71M | 4.90% | 
| Dec 31, 2021 | 55.26M | 1.93M | 3.61% | 
| Dec 31, 2020 | 53.34M | -11.35M | -17.54% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| UnitedHealth Group | 435.16B | 
| Johnson & Johnson | 92.15B | 
| Merck & Co. | 64.24B | 
| AbbVie | 59.64B | 
| Eli Lilly and Company | 59.42B | 
| AstraZeneca | 56.50B | 
| Novartis AG | 56.37B | 
| Novo Nordisk | 49.11B | 
XTNT News
- 1 hour ago - Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025 - PRNewsWire
 - 2 months ago - Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - PRNewsWire
 - 3 months ago - Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript - Seeking Alpha
 - 3 months ago - Xtant Medical Reports Second Quarter 2025 Financial Results - PRNewsWire
 - 3 months ago - Xtant Medical to Attend the CG 45th Annual Growth Conference - PRNewsWire
 - 3 months ago - Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025 - PRNewsWire
 - 4 months ago - Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine - PRNewsWire
 - 5 months ago - Xtant Medical Announces the Launch of OsteoFactor Pro™ - PRNewsWire